Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
74.50
-0.71 (-0.94%)
At close: Jan 22, 2026
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 9.68 billion as of January 22, 2026. Its market cap has increased by 28.63% in one year.
Market Cap
9.68B
Enterprise Value
8.89B
Revenue
1.21B
Ranking
n/a
PE Ratio
53.23
Stock Price
74.50
Market Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 9.68B, an increase of 59.23%. That is a compound annual growth rate of 8.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 9.68B | 3.10% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |